Passive transfer failure in horses: incidence and causative factors on a breeding farm

A prospective study was performed to determine the incidence and associated maternal and managemental factors of failure of passive transfer (FPT) in foals on a breeding farm. The zinc sulfate turbidity test (ZSTT) and latex agglutination test (LAT) were compared for accuracy in estimating serum immunoglobulin (Ig)G of foals, as determined by single radial immunodiffusion (SRID). Complete past and present foaling histories of 136 Standardbred mares were obtained. All foalings were witnessed by farm attendants, and colostral samples were collected from mares within 2 hours after parturition. Foals that did not rise and nurse were supplemented with colostrum from the dam, using a bottle or nasogastric tube. Serum samples were prepared from foals and mares between 24 and 36 hours after parturition, and from some mares 45 to 90 days before parturition. Serum IgG concentrations of mares and foals and colostral whey were determined, using SRID. Serum IgG also was estimated in foals, using ZSTT and a commercially available LAT. Four of the 136 foals (2.9%) had FPT (serum IgG less than or equal to 400 mg/dl). Serum IgG concentrations in foals significantly correlated with colostral IgG (P less than 0.001). A significantly larger proportion of foals with FPT were bottle-fed their colostrum (P less than 0.01). Month of parturition, mare age, parity, number of barren seasons, incidence of assisted births or retained placenta, or prepartum serum IgG concentrations did not significantly affect colostral IgG concentrations or serum IgG concentrations in foals. As serum IgG concentrations in foals decreased and as colostral IgG concentrations decreased, the proportion of mares that prelactated significantly (P less than 0.01) increased.(ABSTRACT TRUNCATED AT 250 WORDS)     

Factors Associated with Failure of Passive Transfer of Colostral Antibodies in Standardbred Foals

The records of 361 Standardbred mares and their 1986 or 1987 foals were evaluated to identify factors associated with failure of passive transfer (FPT) of colostral antibodies in equine neonates. Sixty-five foals (18%) were classified as FPT based on a serum immunoglobulin concentration of less than 400 mg/dl at 24 to 36 hours of age, determined by the glutaraldehyde coagulation test. The potential association of mare- and foal-related factors with FPT were assessed by reviewing a series of multiple logistic regression models. The season in which the mare foaled and foal exam score, a subjective assessment of foal vigor, maturity, and general health, were the primary factors associated with the development of FPT. Foals with FPT were more likely (odds ratio = 3.50; 95% confidence interval = 1.81-6.68) than normal foals to require medical therapy during the first 3 months after parturition.     

Relationships among serum immunoglobulin concentration in foals, colostral specific gravity, and colostral immunoglobulin concentration

Postpartum, presuckle, colostrum samples were collected from 100 mares. Colostral specific gravities significantly correlated (r = 0.9) with colostral immunoglobulin (Ig)G concentrations. Foal serum IgG concentrations highly correlated (r = 0.82) with specific gravities of the colostrum each foal ingested. Eight of 48 foals (17%) had serum IgG concentrations less than 400 mg/dl. The dams of these 8 foals had colostral sp gr less than 1.06 and colostral IgG concentrations less than 3,000 mg/dl. Foals had serum IgG concentrations greater than 520 mg/dl 24 hours after parturition, when the colostral specific gravity of the dam was greater than or equal to 1.06. Effects of breed on colostral specific gravity, colostral IgG concentrations, foal serum IgG concentrations, and mare serum IgG concentrations were not significant.     

The incidence and consequences of failure of passive transfer of immunity on a Thoroughbred breeding farm

Circulating IgG concentration was determined between 12 and 24 hours after birth for 323 foals born on a Thoroughbred breeding farm over 3 consecutive years. The incidence of failure of passive transfer (FPT) of maternal immunoglobulins (foal circulating IgG concentration < 8 g/L) was found to be 9.6%. Foals born late in the season (October to December) were found to be at increased risk for the development of FPT. The degree of assistance required at parturition and the presence of a periparturient problem in the mare or foal also significantly influenced the subsequent incidence of FPT. Passive immune status significantly influenced the likelihood of foals developing septic illness (joint ill, septicaemia, pneumonia) in the first month of life, but had no significant effect on the development of diarrhoea or Rhodococcus equi pneumonia. The results of the current study support the value of routine monitoring of passive immune status and the early speculative treatment of foals considered to be at risk for the development of FPT.     

Investigation of the gamma-check-c test as a means of evaluating IgG levels in equine colostrum

One hundred and seventy-eight colostrum samples from 90 mares were evaluated for adequate IgG content (≥ 3800 mg/dl) using the GAMMA-CHECK-C test. A positive test is based on the ability of glutaraldehyde to react with gammaglobulin to form a solid clot. When the GAMMA-CHECK-C test was compared to colostral IgG values of ≥ or < 3800 mg/dl obtained by radial immunodiffusion and to a colostral specific gravity of ≥ or < 1.060 as measured by a colostrometer, the positive predictive value was 100% and 98.2% and the negative predictive value 88.9% and 95.7%, respectively. In this population of mares 11/80 had pre-suckle colostral IgG levels of < 3800 mg/dl. Three foals suckling colostrum positive to the GAMMA-CHECK-C test (IgG ≥ 3800 mg/dl) showed high levels of IgG as early as 3 hr post-suckle (740, 810 and 1400 mg/dl). One foal suckling colostrum negative to the GAMMA-CHECK-C test, who received no supplemental colostrum, had an IgG < 400 mg/dl at 24 hr of age. GAMMA-CHECK-C is a quick, easy and economical field test for the semi-quantitative determination of colostral IgG.     

Studies of passive immunity in foals to equine viral arteritis

The capacity of colostral samples collected from mares immune to equine viral arteritis to neutralize arteritis virus was two or more times greater than that present in the dams' sera. This activity in the mammary secretions was very low or undetectable after 1 week. The capacity of sera from eight of the nine foals born to immune mares to neutralize arteritis virus was high at 1 week of age. All of the titres had declined to extinction after 2–6 months. Arteritis virus neutralization was not detected in serum collected from foals prior to nursing or in samples from non-immune mares and their foals.Foals from immune mares developed mild signs or no signs of disease when inoculated nasally with virulent arteritis virus at 6 days of age.Seven- to nine-day-old foals from non-immune mares responded to vaccinationas they had appreciable serum-virus neutralizing antibody titres 6 months after vaccination and did not develop signs of disease when inoculated nasally with virulent virus. Foals of the same ages from immune mares did not respond to the vaccine since antibody could not be detected 6 months after vaccination and they either died or experienced clinically severe disease when inoculated nasally with virulent arteritis virus.     

A follow up study on antibodies against Lawsonia intracellularis in mares and foals from two breeding farms in Germany

Equine proliferative enteropathy (EPE) caused by Lawsonia (L.) intracellularis is an emerging disease in foals, particularly in North America. Since a case report in Germany exists, the objective of this study was to examine the incidence of L. intracellularis-antibodies in healthy horses from two German breeding farms. In group 1, serum samples from 24 (year 1) and 16 (year 2) Haflinger mares and their foals were taken. In group 2, over a period of five months, serum samples of six warmblood mares and foals were collected monthly from birth until the foals became seronegative. Serum samples were tested using an ELISA system. Results are expressed as Percentage of Inhibiton (PI). All adult mares (100%) of both groups were seropositive at each point in time (PI-value > 30). In group 1,7/24 foals (29.2%) in year 1 and 4/16 foals (25%) in year 2 had antibodies.The seropositive foals from year 2 had the same dams as the seropositive foals from year 1. In group 2 five of six foals were seropositive after birth. Antibodies decreased from March to July in mares and foals. In July, all five foals tested negative for the first time between the ages of 82 and 141 days (median 115 days). PI-values of mares were significantly correlated with PI-values of their foals. Higher PI-values were seen in younger foals and early in spring. Loss of antibodies in foals at the age of three to five months could be a risk factor for infection and appearance of EPE.     

Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals

OBJECTIVE: To determine efficacy of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. DESIGN: Randomized clinical trial. ANIMALS: 165 foals. PROCEDURE: Foals were randomly assigned to 1 of 2 groups (hyperimmune plasma or nontreated controls). Foals with failure of passive transfer (FPT) of immunity were treated with hyperimmune plasma and evaluated as a third group. Foals that received plasma were given 950 ml between 1 and 10 days of age and between 30 and 50 days of age. A tracheobronchial aspirate was obtained from foals with clinical signs of respiratory tract disease for bacteriologic culture. RESULTS: A significant difference in incidence of pneumonia caused by R equi in foals with adequate passive transfer was not detected between foals that received plasma (19.1%) and nontreated foals (30%). Of 13 foals without FPT that received plasma and developed pneumonia caused by R equi, 12 developed disease prior to administration of the second dose of hyperimmune plasma. Incidence of undifferentiated pneumonia of all causes was not different between groups. CONCLUSION AND CLINICAL RELEVANCE: Intravenous administration of the commercially available hyperimmune plasma was safe, and the product contained high concentrations of anti-R equi antibodies. However, within this limited foal population, the difference in incidence of pneumonia caused by R equi observed between foals that received plasma and control foals was not significant.     

Serological status of mares in parturition and the levels of antibodies (IgG) against protozoan family Sarcocystidae from their pre colostral foals

Protozoa from the family Sarcocystidae are agents of reproductive and neurological disorders in horses. The transmission of these protozoa may occur via horizontal or vertical means, and the frequency and potential of the later is not fully elucidated in horses. Thus, the aim of study was to correlation levels of antibodies in mares with pre colostral foals seropositive and assess the level and distribuition of antibodies against Neospora spp., Sarcocystis neurona and Toxoplasma gondii, in mares and pre colostral foals at the parturition. The blood samples were collected from mares immediately after parturition and from newborns before the ingestion of colostrum, and sera were analyzed for the presence of IgG by ELISA. It was found that 21.5%, 33.7% and 27.6% of mares were seropositive for Neospora spp., S. neurona and T. gondii, respectively; foals had antibodies at a rate of 8.3%, 6.6% and 6.6% for Neospora spp., S. neurona and T. gondii, respectively. Additionally, paired samples from mares and pre-colostral foals revealed an overall negative correlation between the serum reactivity against these three parasites and suggested that seronegative mares, or those with low to intermediate antibody levels, have a higher risk of giving birth to seropositive foals.     

An attempt to determine the tissue origin of equine serum alkaline phosphatase by isoelectric focusing.

The main purpose of this study was to ascertain whether isoelectric point determination of alkaline phosphatase (AP) using an isoelectric focusing technique on agarose gels could define the isoenzymes present in healthy equine serum. The isoelectric points of AP extracted from nine tissues ranged from pH 3.5 to 7.5 with all tissues having multiple bands. There was considerable similarity in band pattern among tissues, with only pancreatic and colostral AP having substantially different isoelectric points from the others. Sera contained thirteen bands with isoelectric points ranging from pH 3.5 to 6.2 and as each band was common to more than one tissue it was not possible to define the tissue origin of these by direct comparison with tissue patterns. The intensity of all serum bands declined as foals aged, with the greatest decrease in bands 4 and 5 (numbered from the anode). There was no relative change in the banding pattern between early and late pregnant mares or in the sera of two foals before and after ingestion of colostrum. The mean (+/- SD) total serum AP activities of young foals (1676 +/- 1100 IU/L), three month foals (402 +/- 64 IU/L) early pregnant (190 +/- 54 IU/L) and late pregnant mares (109 +/- 26 IU/L) were significantly different from each other whereas colostral ingestion in two neonatal foals had no effect. We concluded that equine AP is a very heterogeneous protein and that normal horse sera do not contain significant renal or small intestinal derived AP. However isoelectric focusing alone could not differentiate bone from liver derived AP in sera.     

Ulcerative dermatitis, thrombocytopenia, and neutropenia in neonatal foals

This report describes transient ulcerative dermatitis, severe thrombocytopenia, and mild neutropenia in 6 foals from 4 mares from geographically diverse regions of the United States. The foals presented at <4 days of age with oral and lingual ulcers, and crusting and erythema around the eyes, muzzle, and perineal, inguinal, axillary, trunk, and neck regions. There was a severe thrombocytopenia (0-30,000 platelets/microL), leukopenia (1900-3200 white blood cells/microL), and mild neutropenia (500-1800 neutrophils/microL). Four of the 6 foals had petechiae and ecchymotic hemorrhages and 3 had bleeding tendencies. Results of examination of a bone marrow biopsy from 1 foal were normal and results of a platelet surface immunoglobulin test in another were negative. Histopathology of the skin in all foals showed subepidermal clefting with subjacent vascular dilation, dermal hemorrhage, and superficial papillary necrosis. The foals were treated supportively with broad-spectrum antibiotics (5/6), corticosteroids (3/6), gastric ulcer prophylaxis (6/6), whole-blood transfusion (4/6), and platelet-rich plasma (1/6). The skin lesions and thrombocytopenia (>50,000 platelets/microL) improved in 2 weeks (4/6). Two foals had a decline in their platelet counts when the steroids were decreased and needed protracted treatment. All foals survived and were healthy as yearlings. Two mares that had 2 affected foals each, upon subsequent pregnancies to different stallions, had healthy foals when an alternate source of colostrum was given. The findings in the cases in this report suggest a possible relationship between colostral antibodies or some other factor in the colostrum and the thrombocytopenia and skin lesions, although further investigation is warranted to confirm or refute this hypothesis.     

Failure of passive transfer of colostral immunity in the foal: incidence, and the effect of stud management and plasma transfusions.

The importance of colostrum for the passive transfer of maternal immunity to foals is well recognised. This survey reports the incidence of the failure of passive transfer of colostral immunity in thoroughbred foals in the United Kingdom during 1988 to 1990, and the effect of plasma transfusions on IgG levels in a group of them. The incidence of disease in these foals first month of life is also recorded.     

A Field Study of Serum,Colostrum, Milk Iodine,and Thyroid Hormone Concentrations in Postpartum Draft Mares and Foals

Iodine, thyroxine (T4) and triiodothyronine (T3) are required for normal fetal growth, maturation, and neonatal survival. There is a lack of robust information on iodine levels found in colostrum, milk, and serum of mares and foals after a healthy pregnancy. Our objective was to characterize colostrum, milk, and serum iodine levels in healthy postpartum mares and foals (n = 10) and explore relationships with thyroid hormone concentrations. Colostrum, milk, and jugular blood samples from draft breed mares and foals with an estimated average iodine daily intake of 39 mg per mare during pregnancy were obtained at Day 0 (foaling date) and/or 10 days later. Parameters studied were (1) mare basal concentrations of serum: TT3, TT4, and iodine; (2) iodine in colostrum at Day 0 and milk iodine (Day 10); and (3) foal basal: TT3, TT4, and serum iodine (Days 0 and 10). Median ± median error colostrum iodine levels (165 ± 15.1 μg/L) were higher than milk (48 ± 5.6 μg/L; P = .007) levels. Median ± median error foal serum iodine (268.5 ± 7.6 μg/L), TT4 (1,225 ± 47.8 nmol/L), and TT3 (14.2 ± 1.1 nmol/L) at foaling date were higher than at 10 days (serum iodine: 70 ± 3.6 μg/L; TT4: 69.6. ± 20.4 nmol/L; and TT3: 5.4 ± 0.3 nmol/L). In conclusion, equine mammary tissue concentrates iodine beyond plasma levels, making colostrum and milk a significant source of iodine. Foal serum iodine levels are high in the neonatal period and are positively correlated with TT4, which is important for neonatal adaptation.     

Factors that influence passive transfer of immunoglobulins in foals.

Effects of farm management, breed, mare age, gestation duration, and climatologic factors on colostral specific gravity, colostral IgG concentration, and foal serum IgG concentration were evaluated. Climatologic variables measured were daily maximal, minimal, and mean air temperature, precipitation, average relative humidity, and total solar radiation. Presuckle, postpartum colostrum samples were collected from 140 Standardbred, 94 Thoroughbred, and 59 Arabian mares from January through June during 1985 and 1986. Thoroughbred (farm A, n = 61; farm B, n = 33) and Arabian (farm C, n = 45; farm D, n = 14) mares were located in Ocala, Fla; Standardbred mares (farm E) were in Montgomery, NY. Mares from farms A, B, D, and E foaled in box stalls, and mares from farm C foaled in sand paddocks. Mares with premature lactation greater than 12 hours were not included in the study. Foals were clinically normal at birth and suckled colostrum without assistance within 2 hours of parturition. Specific gravity of presuckle colostrum samples was measured by use of an equine colostrometer. Blood samples were collected 18 hours after parturition from 253 of the 293 foals (n = 45, 25, 32, 13, 138 on farms A through E, respectively) to determine serum concentration of IgG. The IgG concentrations in colostrum and serum were measured by single radial immunodiffusion. Data were analyzed by multiple regression or chi 2 analysis. The most important determinants of foal serum IgG concentration were the IgG content and specific gravity of presuckle colostrum samples (P less than 0.0001).(ABSTRACT TRUNCATED AT 250 WORDS)     

Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd

Horses naturally exposed to West Nile Virus (WNV) or vaccinated against WNV develop humoral immunity thought to be protective against development of clinical disease in exposed or infected animals. No reports evaluate the efficacy of passive transfer of naturally acquired specific WNV humoral immunity from dam to foal. The purpose of this study was to investigate passive transfer of naturally acquired immunity to WNV to foals born in a herd of semi-feral ponies, not vaccinated against WNV, in an endemic area, with many dams having seroconverted because of natural exposure. Microwell serum neutralization titers against WNV were determined in all mares and foals. Serum IgG concentration was determined in foals by serial radial immunodiffusion. Differences in IgG concentration between seropositive and seronegative foals were examined by means of the Mann-Whitney U-test. Linear regression was used to evaluate the association between mare and foal titers. Seventeen mare-foal pairs were studied; 1 foal had inadequate IgG concentration. IgG concentration was not different between seronegative and seropositive foals (P = .24). Mare and foal titers were significantly correlated in foals with adequate passive transfer of immunity (Spearman's rho = .84; P < .001); >90% of the foal's titer was explained by the mare's titer (R2 = 0.91; P < .001). Passive transfer of specific immunity to WNV is present in pony foals with adequate passive transfer of immunity born to seroconverted mares.     

The Effects of Ivermectin Given Postpartum on the Incidence and Severity of Foal Heat Diarrhea

Foal heat diarrhea (FHD) is a major factor in the management of foals between 2 and 3 wk of age. The objective of this on-farm study was to determine the efficacy of postpartum anthelmintic treatment of mares for reducing the incidence and/or the severity of FHD in foals caused by parasitic infestation. Twenty-four Quarter Horse mares and their foals were alternately assigned to a treated or non-treated group according to expected foaling date. Treatment consisted of oral administration of Zimectrin® (Farnam Companies, Inc., Phoenix, AZ) to the dam within 12 h post-foaling. From d l through 25, foals were weighed, and vital signs and severity or absence of diarrhea were recorded. Incidence scores of 0 to 3 were assigned to each foal based on severity of diarrhea: 0 = no affliction and 3 = severe, watery diarrhea. There was no difference in incidence scores because of treatment; however, there was a trend for foals from treated mares to experience more severe diarrhea with a shorter duration. There was no difference in BW gain related to treatment or nontreatment of mares. Postpartum administration of Zimectrin to mares did not significantly decrease the incidence or severity of diarrhea in foals. Additionally, it did not affect growth rate of foals. The trend for foals from treated mares to have a shorter duration of FHD may be beneficial to farm managers who spend time and money treating and cleaning foals.     

Efficacy and Safety of a Commercial Fresh-Frozen Hyperimmune Plasma in Foals With Failure of Passive Transfer of Immunity

In foals more than 12 hours old, the only effective therapy for the treatment of failure of passive transfer (FPT) of immunity is transfusion of equine plasma. Use and efficacy of equine plasma for prophylaxis and treatment of sepsis, a condition primarily associated with FPT, are widely reported. However, plasma- and recipient-related factors associated with extent of IgG transfer and catabolism are not completely defined. Efficacy and safety of transfusion of a commercial fresh-frozen hyperimmune plasma were evaluated in hospitalized foals younger than 7 days of age with total or partial FPT. Sixty-two foals, classified as affected by FPT only, septic (infection plus systemic inflammatory response syndrome [SIRS]), and nonseptic sick, were included, and serum IgG concentration was measured at admission and 24 hours after plasma transfusion. In 25/62 foals, IgG level after 72 hours was also determined. The impact of different classification criteria for septic foals on IgG transfer was evaluated. Serum IgG measured 24 hours and 72 hours after plasma transfusion was significantly greater than at admission, but no significant difference was found in transfer efficacy (TE) between FPT, FPT septic, and FPT nonseptic foals and no significant difference was found in IgG concentration comparing foals with total and partial FPT or survivors and nonsurvivors. No significant difference was found comparing IgG concentration between bacteremic and nonbacteremic foals and foals with or without SIRS. No foal experienced adverse reactions to plasma transfusion. IgG TE and catabolism did not result significantly affected by the presence of sepsis or illness or by the outcome.     

断奶前马驹与母马粪便菌群多样性分析

试验旨在探究断奶前马驹和母马粪便菌群多样性,为丰富此阶段马驹肠道菌群多样性提供依据。选取5匹5岁（2胎）、平均体重（453.34±54.23）kg、健康的纯血马母马,以及母马所生的5匹马驹,出生日期相近（±5 d）,平均体重（185.65±9.54）kg,3公2母。母马和马驹在相同环境下饲养,母马日粮组成及营养水平相同,马驹除哺乳外采食的粗饲料和精料补充料相同。马驹6月龄断奶,在断奶前1周用灭菌收粪袋采集母马和马驹的粪便样品。结果显示,母马粪便中菌群α多样性Chao1和ACE指数显著高于马驹（P < 0.05）,分别比马驹高18.94%和15.62%;母马与马驹共有的菌种数为1 399个,母马与马驹特有的菌种数分别为150和68个;在门水平,母马与马驹粪便中排在前十的菌分别是厚壁菌门、变形菌门、拟杆菌门、放线菌门、广古菌门、疣微菌门、螺旋体菌门、Unidentified_Bacteria、纤维杆菌门和无壁菌门,母马粪便中厚壁菌门丰度显著高于马驹（P < 0.05）;拟杆菌门母马比马驹高33.93%,差异不显著（P > 0.05）。由此可见,母马粪便菌群多样性显著高于断奶前马驹;母马与断奶前马驹粪便主要菌是厚壁菌门、拟杆菌门和变形菌门,母马粪便中厚壁菌门和拟杆菌门丰度均高于断奶前马驹。     

Effects of vitamin E and selenium administration on pregnant,heavy draft mares on placental retention time and reproductive performance and on white muscle disease in their foals

This study investigated the effects of administering vitamin E and selenium to pregnant heavy draft horsemares on the incidence of retained placenta and postpartum reproductive performance and on the prevention of the white muscle disease in their foals. In study A, 1,000 mg of vitamin E and 50 mg of selenium (E-SE 20 mL) were given to 22 mares 3 weeks before expected parturition (335 days counted from last mating), whereas 28 mares were used as controls. In study B, E-SE were administered 2 weeks before expected parturition at 2 dose levels, with 25 mares receiving 20 mL E-SE, 19 mares receiving 10 mL, and 29 mares kept as controls. Vitamin E and selenium were assayed in serum collected from some of the mares before administration of E-SE and again postpartum and from the foals immediately after birth. Serum selenium concentrations before E-SE administration were deficient (<65 ng/mL) in all mares (n = 48) but were increased in the postpartum sample from treated mares regardless of the dose or timing of administration (n = 31) (P = .05). Only study B mares were deficient in vitamin E prepartum, and both dose levels of E-SE had corrected this in the postpartum sample (P = .01). All foals were selenium deficient regardless of whether their dams had received E-SE or not, although concentrations were higher in foals from treated study A mares than from controls (P = .05). Mares with the highest selenium concentrations prepartum (40 ng/mL and over) had shorter placental retention times than mares with lower selenium concentrations (P = .05) and did not respond to E-SE with a further reduction in retention time. By contrast, mares with prepartum selenium concentrations between 20 and 40 ng/mL tended to respond to E-SE with a shortened placental retention time (P = .07). E-SE administration reduced the mean number of days from parturition to last mating (nonpregnant term) in study B mares (P = .05) and in mares with adequate prepartum vitamin E concentrations (>300 g/mL, P = .05). We conclude that maintaining high level serum vitamin E and selenium concentrations of prepartum mares is expected to increase fertility of selenium-deficient mares. Therefore, the regimen of vitamin E and selenium administrations to selenium deficient mares should be developed.     

Prospective study of progeny of inapparent equine carriers of equine infectious anemia virus

Progeny of a band of horses, positive by the agar-gel immunodiffusion (AGID) test for equine infectious anemia (EIA) antibody, were observed through their weaning over a 4-year period. Sentinels (AGID test-negative) were allowed to mingle with EIA-infected mares and their foals in pasture situations in an area with high populations of potential vectors. Of 27 adult sentinels, 8 (30%) seroconverted in annual rates ranging from 0% to 75%. In contrast, only 2 of 31 (6%) foals weaned became infected. Difference in infection rates between adult sentinels and foals was significant (chi 2, P less than 0.05). Possible explanations for differences included protective value of colostral immunity and differences in attractiveness to blood feeding vectors. Detectable colostral immunity to EIA virus in the AGID test persisted for 25 to 195 days, with a mean of 124 days.